513 related articles for article (PubMed ID: 32788913)
41. The Rationale for Potential Pharmacotherapy of COVID-19.
Saber-Ayad M; Saleh MA; Abu-Gharbieh E
Pharmaceuticals (Basel); 2020 May; 13(5):. PubMed ID: 32423024
[TBL] [Abstract][Full Text] [Related]
42. Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update.
Kumari P; Rawat K; Saha L
Curr Pharmacol Rep; 2020; 6(5):228-240. PubMed ID: 32837854
[TBL] [Abstract][Full Text] [Related]
43. Epidemiological and Clinical Features of SARS-CoV-2: A Retrospective Study from East Karachi, Pakistan.
Tahir S; Tahir SA; Bin Arif T; Majid B; Majid Z; Malik F; Ahmed A; Memon A; Ahmed J
Cureus; 2020 Jun; 12(6):e8679. PubMed ID: 32699679
[TBL] [Abstract][Full Text] [Related]
44. Human Immunodeficiency Virus: A Dark Cloud With Silver Lining During the COVID-19 Pandemic.
Pata RK; Ahmady A; Kiani R
Cureus; 2020 Jul; 12(7):e9302. PubMed ID: 32832299
[TBL] [Abstract][Full Text] [Related]
45. Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenza virus therapies.
Liao J; Way G; Madahar V
Med Drug Discov; 2020 Mar; 5():100037. PubMed ID: 32292909
[TBL] [Abstract][Full Text] [Related]
46. Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2.
Valencia DN
Cureus; 2020 Mar; 12(3):e7386. PubMed ID: 32337113
[TBL] [Abstract][Full Text] [Related]
47. COVID-19 pandemic and its positive impacts on environment: an updated review.
Khan I; Shah D; Shah SS
Int J Environ Sci Technol (Tehran); 2021; 18(2):521-530. PubMed ID: 33224247
[TBL] [Abstract][Full Text] [Related]
48. The Current Clinically Relevant Findings on COVID-19 Pandemic.
Pergolizzi JV; Magnusson P; LeQuang JA; Breve F; Paladini A; Rekatsina M; Yeam CT; Imani F; Saltelli G; Taylor R; Wollmuth C; Varrassi G
Anesth Pain Med; 2020 Apr; 10(2):e103819. PubMed ID: 32754437
[TBL] [Abstract][Full Text] [Related]
49. SARS-CoV-2 infection in children.
Çokuğraş H; Önal P
Turk Pediatri Ars; 2020; 55(2):95-102. PubMed ID: 32684754
[TBL] [Abstract][Full Text] [Related]
50. Analytical insights of COVID-19 pandemic.
Chellasamy G; Arumugasamy SK; Govindaraju S; Yun K
Trends Analyt Chem; 2020 Dec; 133():116072. PubMed ID: 33100439
[TBL] [Abstract][Full Text] [Related]
51. Differentiation of COVID-19 Pneumonitis and ICI Induced Pneumonitis.
Dumoulin DW; Gietema HA; Paats MS; Hendriks LEL; Cornelissen R
Front Oncol; 2020; 10():577696. PubMed ID: 33194697
[TBL] [Abstract][Full Text] [Related]
52. Coronavirus disease 2019 and its vaccines: An update.
Jeddy N; Lakshmi SLJ
J Oral Maxillofac Pathol; 2021; 25(1):5-11. PubMed ID: 34349402
[TBL] [Abstract][Full Text] [Related]
53. Medical Management of COVID-19: Evidence and Experience.
Bose S; Adapa S; Aeddula NR; Roy S; Nandikanti D; Vupadhyayula PM; Naramala S; Gayam V; Muppidi V; Konala VM
J Clin Med Res; 2020 Jun; 12(6):329-343. PubMed ID: 32587649
[TBL] [Abstract][Full Text] [Related]
54. Lactoferrin for the treatment of COVID-19 (Review).
Wang Y; Wang P; Wang H; Luo Y; Wan L; Jiang M; Chu Y
Exp Ther Med; 2020 Dec; 20(6):272. PubMed ID: 33199997
[TBL] [Abstract][Full Text] [Related]
55. Double-Barreled CRISPR Technology as a Novel Treatment Strategy For COVID-19.
Nalawansha DA; Samarasinghe KTG
ACS Pharmacol Transl Sci; 2020 Oct; 3(5):790-800. PubMed ID: 33062949
[TBL] [Abstract][Full Text] [Related]
56. Acute Upper Limb Ischemia Due To Arterial Thrombosis in a Mild COVID-19 Patient: A Case Report.
Hanif M; Ali MJ; Haider MA; Naz S; Ahmad Z
Cureus; 2020 Sep; 12(9):e10349. PubMed ID: 33062472
[TBL] [Abstract][Full Text] [Related]
57. The use of remdesivir outside of clinical trials during the COVID-19 pandemic.
Halimi V; Daci A; Ridova N; Panovska-Stavridis I; Stevanovic M; Filipce V; Dimovski A; Grozdanova A
J Pharm Policy Pract; 2020; 13():61. PubMed ID: 32968487
[TBL] [Abstract][Full Text] [Related]
58. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19).
Kakodkar P; Kaka N; Baig MN
Cureus; 2020 Apr; 12(4):e7560. PubMed ID: 32269893
[TBL] [Abstract][Full Text] [Related]
59. Probability of COVID-19 Being the Culprit in Neurocognitive Deception: A Case Series of Incidental Strokes in ICU Patients With COVID-19.
Pata R; Kiani R; Ahmady A; Awad VM
Cureus; 2020 Aug; 12(8):e9857. PubMed ID: 32963899
[TBL] [Abstract][Full Text] [Related]
60. [Clinical management of COVID-19 paediatric cases].
Montaño-Luna VE; Pacheco-Rosas DO; Vázquez-Rosales JG; Labra-Zamora MG; Fuentes-Pacheco Y; Sámano-Aviña M; Miranda-Novales MG
Rev Med Inst Mex Seguro Soc; 2020 Sep; 58(Supl 2):S246-259. PubMed ID: 34695337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
